共 50 条
Ten years' disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy A case report and literature review
被引:2
|作者:
Zhang, Jue
[1
]
Mei, Liejun
[2
]
Wang, Fubing
[3
]
Li, Yan
[1
]
机构:
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab, Wuhan 430071, Peoples R China
来源:
基金:
北京市自然科学基金;
关键词:
advanced ovarian cancer;
cytoreductive surgery;
hyperthermic intraperitoneal chemotherapy;
peritoneal carcinomatosis;
HIPEC;
PACLITAXEL;
CISPLATIN;
D O I:
10.1097/MD.0000000000023404
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Rationale: One of the most distinctive features of epithelial ovarian cancer is tendency to disseminate into peritoneal cavity to form peritoneal carcinomatosis, indicating advanced disease with poor prognosis. Patient concerns: A fifty-year-old patient had a chief complaint of an abdominal distension lasting 1 month. Diagnoses: The patient was diagnosed with advanced epithelial ovarian cancer with peritoneal carcinomatosis by computed tomography scan, tumor markers, endoscopy examination, and pathology. Interventions: The patient was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy followed by 8 cycles of systemic chemotherapy. Outcomes: Till March 9, 2020, the patient has disease-free survival over 10 years. Lessons: The application of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy combined with systematic chemotherapy may improve survival dramatically for the patients with epithelial ovarian cancer and peritoneal carcinomatosis and should be considered as an option of a relatively new regime.
引用
收藏
页数:5
相关论文